d) - auch als Quereinstieg möglich at Acadia Pharmaceuticals

Kiel, Schleswig-Holstein, Germany

Apply Now

Not SpecifiedCompensation

Entry Level & New GradExperience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Skills

Key technologies and capabilities for this role

Machine OperationGMP DocumentationCleanroom ProceduresHygiene AwarenessTechnical ProcessesMS Office

Questions & Answers

Common questions about this position

Is this role remote or onsite?

This is an onsite position located in Kiel, Germany.

What education or experience is required for this Operator Sterile Production role?

A Pharmacy Assistant (Pharmakant), Chemist (Chemikant), or comparable education in a technically oriented profession like Chemistry, Biology, Pharma, Medicine, or Food Technology is required. Ideally, some prior experience in the manufacture of sterile pharmaceuticals is preferred.

What key skills are needed for this position?

Key skills include openness to technical processes, practical skills for machine operation, above-average cleanliness and hygiene awareness, good knowledge of GMP-compliant documentation and cleanroom behavior, safe handling of MS Office (especially Excel and Outlook), teamwork, communication, and willingness to work various shift patterns including weekends.

What is the company culture like at Ferring GmbH?

Ferring GmbH emphasizes teamwork and collaboration, with a mission to change the lives of millions of people by working together successfully. The Kiel site employs approximately 450 staff dedicated to producing vital pharmaceutical products.

Is this position open to career changers with no prior experience?

Yes, the role is open to Quereinstieg (career changers), and while prior experience in sterile pharmaceuticals is ideal, it is not strictly required if candidates have the specified education and skills.

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free